FDA Inspection 1097119 — 23andMe Genomics LLC
The FDA completed an inspection of 23andMe Genomics LLC on Jun 13, 2019 in Palo Alto, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 13, 2019
- Fiscal Year
- 2019
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Palo Alto, CA (United States)